A carregar...

Imatinib Mesylate for Patients With Unresectable or Recurrent Gastrointestinal Stromal Tumors: 10-Year Experience From Vietnam

Only limited data are available concerning the long-term outcomes of imatinib treatment among Vietnamese or Asian patients with unresectable or recurrent gastrointestinal stromal tumors (GISTs). Our study, which was conducted in 188 patients, aimed to assess the efficacy of imatinib mesylate against...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Control
Main Authors: Hung, Kien Do, Van, Quang Le, Hoang, Gia Nguyen, Bich, Phuong Nguyen Thi
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6643187/
https://ncbi.nlm.nih.gov/pubmed/31319677
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1073274819863776
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!